Internal Medicine, Endocrinology, Diabetes, & Metabolism · Chicago, IL
NPI
1083774889
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
676 N Saint Clair St Ste 701
Chicago, IL, 60611
Phone (312) 695-7970
Groups this clinician bills Medicare through
Medicare paid, 2024
$671K
44,830 services
Medicare patients, 2024
1,355
Average age 75
Drug cost, 2024
$1.6M
1,181 prescriptions
Company payments, 2023
$79.4
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Allison J Hahr was code J3111 (injection, romosozumab-aqqg, 1 mg), 26,460 times for 27 patients. In total Allison J Hahr billed 44,830 services in 27 codes, and Medicare paid $671K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 26,460 | 27 | $8.37 | $221K |
| J0897 Injection, denosumab, 1 mg | Office | 15,660 | 153 | $20.36 | $319K |
| 77080 Standard X-ray | Office | 811 | 811 | $41.04 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 515 | 481 | $12.92 | $6,653 |
| 96372 Injection Administration | Office | 511 | 177 | $12.01 | $6,138 |
| 99214 Office E&M - Established | Office | 444 | 426 | $95.82 | $43K |
| 99215 Office E&M - Established | Office | 98 | 90 | $136.38 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 97 | 32 | $65.36 | $6,340 |
| 99204 Office E&M - New | Office | 58 | 58 | $128.91 | $7,477 |
| 99205 Office E&M - New | Office | 39 | 39 | $175.39 | $6,840 |
| 99443 Telephone Services | Office | 26 | 26 | $97.17 | $2,526 |
| 99222 Hospital E&M - Initial | Facility | 24 | 24 | $112.51 | $2,700 |
| 36415 Venipuncture Blood Collection | Office | 23 | 23 | $8.65 | $199 |
| 95251 Test - Miscellaneous | Office | 17 | 11 | $29.34 | $499 |
By year: 2022 $967K for 56,060 services; 2023 $685K for 51,519 services; 2024 $671K for 44,830 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 23 | $8.65 | $199 |
Medicare prescription drug claims, 2024
In 2024, the drug Allison J Hahr prescribed most often to Medicare patients was Levothyroxine Sodium, with 245 prescriptions and refills. In total Allison J Hahr wrote 1,181 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 245 | 698 | 73 | $3,844 |
| Alendronate Sodium Generic | 214 | 568 | 76 | $1,964 |
| Synthroid Levothyroxine Sodium | 131 | 374 | 37 | $12K |
| Calcitriol Generic | 54 | 110 | 12 | $1,175 |
| Tymlos Abaloparatide | 53 | 61 | Under 11 | $159K |
| Methimazole Generic | 44 | 90 | Under 11 | $299 |
| Forteo Teriparatide | 38 | 38 | Under 11 | $154K |
| Chlorthalidone Generic | 36 | 99 | 13 | $410 |
| Hydrocortisone Generic | 24 | 52 | Under 11 | $1,327 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 23 | 53 | Under 11 | $3,270 |
| Crysvita Burosumab-Twza | 23 | 23 | Under 11 | $1.2M |
| Risedronate Sodium Generic | 21 | 53 | Under 11 | $1,026 |
| Potassium Chloride Generic | 20 | 58 | Under 11 | $1,046 |
| Hydrochlorothiazide Generic | 19 | 57 | Under 11 | $101 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 17 | 48 | Under 11 | $2,466 |
Brand drugs: 481 claims; generic drugs: 661 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Allison J Hahr $79.4 ($79.4 in general payments such as food, travel and fees) from 1 company. The largest payer was Mannkind Corporation with $79.4.
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation MNKD | 2 | $79.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.